恩华药业 (002262.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(恩华药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 72.0072.0074.0073.0076.0077.0076.0075.00
 单季度销售净利率(%) 11.0027.0026.0019.0012.0026.0025.0019.00
 单季度净资产收益率ROE(%) 2.006.005.004.003.006.005.004.00
 单季度总资产净利率ROA(%) 2.005.005.003.002.005.004.003.00
单季度财务摘要:
 单季度营业总收入(元) 1,385,519,288.001,255,656,387.001,221,522,303.001,178,806,488.001,178,387,351.001,119,026,744.001,008,505,778.00992,593,189.00
 单季度营业总成本(元) 1,251,964,325.00885,932,213.00864,431,140.00909,691,076.001,073,149,025.00791,817,751.00706,729,247.00787,121,463.00
 单季度营业收入(元) 1,385,519,288.001,255,656,387.001,221,522,303.001,178,806,488.001,178,387,351.001,119,026,744.001,008,505,778.00992,593,189.00
 单季度营业利润(元) 176,887,292.00379,364,831.00364,512,485.00261,579,559.00154,579,374.00334,259,382.00304,934,074.00209,692,665.00
 单季度利润总额(元) 167,869,258.00378,785,058.00363,490,071.00258,499,710.00145,748,876.00332,810,860.00303,124,361.00208,222,790.00
 单季度净利润(元) 150,832,622.00339,006,272.00319,234,997.00225,173,396.00144,536,166.00292,527,528.00256,584,399.00186,740,460.00
 单季度归属母公司股东的净利润(元) 151,276,751.00340,938,293.00317,273,601.00227,429,413.00159,051,214.00294,370,924.00258,815,195.00188,688,696.00
 单季度经营活动产生的现金流量(元) 189,651,267.00372,904,329.0081,348,612.00364,395,839.00220,767,838.00244,797,550.00109,286,829.00286,170,933.00
 单季度投资活动产生的现金流量(元) -225,562,397.00-262,521,064.00582,304,155.00-387,611,609.00-486,716,121.00-146,459,026.0030,015,869.00-85,742,885.00
 单季度筹资活动产生的现金流量(元) 16,382,030.00-11,024,657.00-224,561,844.009,030,785.00-7,566,542.00-13,120,700.00-203,654,210.00-16,437,186.00
 单季度现金及现金等价物净增加(元) -19,143,337.0099,360,645.00439,099,408.00-14,166,510.00-272,470,358.0085,111,897.00-64,408,965.00184,017,720.00

前瞻产业研究院